837 resultados para interprofessional collaboration
Resumo:
The main aim of this thesis was to find out what kinds of risks arise from collabo-ration in R&D between small and large firms. The suitability and gain of some buyer/supplier risk frameworks in examining of R&D collaboration has been in-vestigated. A risk model has been based on the buyer/supplier risks models found in the literature. Its applicability has been tested empirically by means of theme interviews with firm representatives. The risk classification framework received some confirmation. But the study also showed that the theoretical framework was not completely adequate, as a new risk class arose from communication. Collaboration causes risks, and these risks should be taken into account when R&D collaboration is planned. The advantage of risk examination is the possibility to decrease failures and losses, and to in-crease possibilities for success and economical benefits. This study should be used as a managerial analysis tool in trying to understand the form and concept of risk in risk expectancy.
Resumo:
Contexte: Le Programme cantonal diabète se développe depuis 2010 dans le canton de Vaud. Il a pour objectif de limiter l'évolution de l'incidence du diabète et d'améliorer la prise en charge des patients diabétiques. - Méthodes: Cette étude vise à recueillir des données concernant : 1) la collaboration interprofessionnelle, 2) la pratique professionnelle au regard du « Chronic care model », ainsi que 3) la connaissance et la mise en pratique des recommandations pour la pratique clinique (RPC) auprès du patient diabétique. Les professionnels de santé (PdS) suivant ont été sollicités pour participer à cette étude : médecins et infirmier(ère)s spécialisé(e)s en diabétologie, médecins de premiers recours et infirmier(ère)s en soins généraux. Cette étude comporte un volet quantitatif où les PdS étaient invités à répondre à un questionnaire sur Internet, et un volet qualitatif où des PdS ont été réunis lors de trois focus groups pour recueillir leurs avis sur les trois thématiques de l'étude.
Resumo:
BACKGROUND: The impact of early valve surgery (EVS) on the outcome of Staphylococcus aureus (SA) prosthetic valve infective endocarditis (PVIE) is unresolved. The objective of this study was to evaluate the association between EVS, performed within the first 60 days of hospitalization, and outcome of SA PVIE within the International Collaboration on Endocarditis-Prospective Cohort Study. METHODS: Participants were enrolled between June 2000 and December 2006. Cox proportional hazards modeling that included surgery as a time-dependent covariate and propensity adjustment for likelihood to receive cardiac surgery was used to evaluate the impact of EVS and 1-year all-cause mortality on patients with definite left-sided S. aureus PVIE and no history of injection drug use. RESULTS: EVS was performed in 74 of the 168 (44.3%) patients. One-year mortality was significantly higher among patients with S. aureus PVIE than in patients with non-S. aureus PVIE (48.2% vs 32.9%; P = .003). Staphylococcus aureus PVIE patients who underwent EVS had a significantly lower 1-year mortality rate (33.8% vs 59.1%; P = .001). In multivariate, propensity-adjusted models, EVS was not associated with 1-year mortality (risk ratio, 0.67 [95% confidence interval, .39-1.15]; P = .15). CONCLUSIONS: In this prospective, multinational cohort of patients with S. aureus PVIE, EVS was not associated with reduced 1-year mortality. The decision to pursue EVS should be individualized for each patient, based upon infection-specific characteristics rather than solely upon the microbiology of the infection causing PVIE.
Resumo:
1899 (A1).
Resumo:
1902 (A4)-1903.
Resumo:
1902/12 (A3).